Cost-effectiveness analysis for joint pain treatment in patients with osteoarthritis treated at the Instituto Mexicano del Seguro Social (IMSS): Comparison of nonsteroidal anti-inflammatory drugs (NSAIDs) vs. cyclooxygenase-2 selective inhibitors

Table 2 Severe adverse event probabilities

Drugs	Peptic symptoms	GI bleeding	Adverse cardiovascular events	Nephrotoxicity
Celecoxib	0.50	0.0046	0.0039	0.0069
Nonselective NSAIDs	0.618	0.0136	0.0047	0.009
Acetaminophen	0.343	0	0	0

ISSN: 1478-7547